Pj. Higgins et al., Differential regulation of PAI-1 gene expression in human fibroblasts predisposed to a fibrotic phenotype, EXP CELL RE, 248(2), 1999, pp. 634-642
Synthesis of the major negative physiologic regulator of plasmin activation
[plasminogen activator inhibitor type-1 (PAI-1)] is elevated during progre
ssive cellular senescence, in premature aging disorders (e.g., Werner's syn
drome), and in conditions associated with tissue fibrosis and excessive fib
rin accumulation (e.g., sclerosis, keloid formation). Dermal fibroblasts de
rived from Werner's patients as well as from keloid lesions markedly overex
press PAI-1 mRNA transcripts compared to normal skin fibroblasts. Such cell
type-related differences in steady-state PAI-1 mRNA content, and variances
in the relative abundance of the 3.0- compared to the 2.2-kb PAI-1 mRNA sp
ecies, served to discriminate normal from Werner's and keloid fibroblasts.
This disparity in PAI-1 mRNA levels paralleled transcriptional activities o
f the PAI-1 gene; de no;o synthesis of PAI-1 protein among the three cell t
ypes, moreover, closely approximated the respective differences in total PA
I-1 mRNA content. Despite the markedly elevated levels of PAI-1 mRNA and pr
otein evident in newly confluent keloid fibroblasts, these cells effectivel
y suppressed PAI-1 synthesis (as did normal dermal fibroblasts) upon cultur
e in serum-free medium. Werner's syndrome skin fibroblasts, in contrast, co
ntinued to maintain high-level PAI-1 expression even after 3 days of growth
arrest. Adhesion-mediated attenuation of serum-stimulated PAI-1 expression
, a characteristic of normal cells involving sequences which mapped to the
distal 5' flanking region of the PAI-1 gene, was retained in keloid but not
Werner's fibroblasts. Collectively, these data suggest that (1) specific c
ontrols on PAI-1 gene expression are fundamentally different between these
two clinically significant high PAI-1-synthesizing cell types and (2) the l
ocalized keloid may define the emergence of a distinct profibrotic dermal f
ibroblastoid phenotype in genetically predisposed individuals. (C) 1991 Aca
demic Press.